Omada Health Q3 revenue rises 34% on cardiometabolic care platform demand
OMDA•OMDA•OMDA•OMDA•Omada Health's third-quarter revenue rose 34% year over year to $91.31 million, while adjusted EBITDA more than doubled to $12 million; both beat analyst expectations. The company raised its 2026 revenue outlook to $344 million-$346 million and adjusted EBITDA outlook to $32 million-$34 million.
Omada Health reported third-quarter revenue of $91.31 million, up 34% year over year and above the $85.68 million analyst consensus. Adjusted EBITDA more than doubled to $12 million, beating the $6.35 million consensus; net income was $7 million and adjusted gross margin was 78%.
The company raised its 2026 revenue forecast to $344 million-$346 million from $334 million-$340 million, and its adjusted EBITDA forecast to $32 million-$34 million from $21 million-$27 million. Total members grew 36% year over year, which the company attributed to demand for its integrated cardiometabolic care platform and enrollment in diabetes and hypertension programs. Average member tenure increased 10% to about two years and four months, CEO Sean Duffy said.
